Literature DB >> 21647471

PURLs: PSA testing: when it's useful, when it's not.

Susan Slatkoff1, Stephen Gamboa, Adam J Zolotor, Anne L Mounsey, Kohar Jones.   

Abstract

Routine PSA testing leads to more diagnoses of prostate cancer, but does not save lives. At least one group of men, however, may reap a small benefit.

Entities:  

Year:  2011        PMID： 21647471      PMCID： PMC3183963     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  8 in total

1.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2008-08-05       Impact factor: 25.391

2.  Comorbidity and mortality results from a randomized prostate cancer screening trial.

Authors:  E David Crawford; Robert Grubb; Amanda Black; Gerald L Andriole; Ming-Hui Chen; Grant Izmirlian; Christine D Berg; Anthony V D'Amico
Journal:  J Clin Oncol       Date:  2010-11-01       Impact factor: 44.544

3.  Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.

Authors:  J L Stanford; Z Feng; A S Hamilton; F D Gilliland; R A Stephenson; J W Eley; P C Albertsen; L C Harlan; A L Potosky
Journal:  JAMA       Date:  2000-01-19       Impact factor: 56.272

Review 4.  Screening for prostate cancer.

Authors:  D Ilic; D O'Connor; S Green; T Wilt
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

5.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

6.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

Review 7.  Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Authors:  Kenneth Lin; Robert Lipsitz; Therese Miller; Supriya Janakiraman
Journal:  Ann Intern Med       Date:  2008-08-05       Impact factor: 25.391

Review 8.  Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials.

Authors:  Mia Djulbegovic; Rebecca J Beyth; Molly M Neuberger; Taryn L Stoffs; Johannes Vieweg; Benjamin Djulbegovic; Philipp Dahm
Journal:  BMJ       Date:  2010-09-14
  8 in total
  5 in total

1.  Knowledge, attitudes, and practices towards prostate cancer screening amongst men living in the southern Italian peninsula: the Prevention and Research in Oncology (PRO) non-profit Foundation experience.

Authors:  Vincenzo Mirone; Ciro Imbimbo; Davide Arcaniolo; Marco Franco; Roberto La Rocca; Luca Venturino; Lorenzo Spirito; Massimiliano Creta; Paolo Verze
Journal:  World J Urol       Date:  2017-08-05       Impact factor: 4.226

2.  The pros and cons of screening.

Authors:  Natasha Gilbert
Journal:  Nature       Date:  2020-03       Impact factor: 49.962

Review 3.  The emerging role of extracellular vesicles as biomarkers for urogenital cancers.

Authors:  Muhammad Nawaz; Giovanni Camussi; Hadi Valadi; Irina Nazarenko; Karin Ekström; Xiaoqin Wang; Simona Principe; Neelam Shah; Naeem M Ashraf; Farah Fatima; Luciano Neder; Thomas Kislinger
Journal:  Nat Rev Urol       Date:  2014-11-18       Impact factor: 14.432

4.  Pairing physician education with patient activation to improve shared decisions in prostate cancer screening: a cluster randomized controlled trial.

Authors:  Michael S Wilkes; Frank C Day; Malathi Srinivasan; Erin Griffin; Daniel J Tancredi; Julie A Rainwater; Richard L Kravitz; Douglas S Bell; Jerome R Hoffman
Journal:  Ann Fam Med       Date:  2013 Jul-Aug       Impact factor: 5.166

5.  Proteolyzed Variant of IgG with Free C-Terminal Lysine as a Biomarker of Prostate Cancer.

Authors:  Anna Lokshin; Lyudmila M Mikhaleva; Eugene I Goufman; Marina N Boltovskaya; Natalia B Tikhonova; Irina I Stepanova; Alexandr A Stepanov; Natalia V Potoldykova; Andrey Z Vinarov; Paul Stemmer; Vasily Iakovlev
Journal:  Biology (Basel)       Date:  2021-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.